UBE2B Antibodies

Santa Cruz Biotechnology features a diverse variety of UBE2B monoclonal antibodies for research focused on understanding UBE2B's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UBE2B, also known as ubiquitin-conjugating enzyme E2 B, plays a central role in the ubiquitin-proteasome system, which is essential for protein degradation and regulation of various cellular functions. UBE2B participates in tagging substrates for degradation, influencing processes such as cell cycle regulation, DNA repair, and signal transduction. Research has shown that UBE2B activity significantly impacts cellular homeostasis and protein quality control mechanisms. Understanding UBE2B function provides valuable insights into disease mechanisms, particularly in cancer and neurodegenerative disorders. Ongoing studies continue to reveal new aspects of UBE2B's biological significance and potential therapeutic applications. Current research utilizing UBE2B monoclonal antibodies has enhanced our understanding of protein degradation pathways and their regulation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge and contribute to breakthrough discoveries in cellular biology and disease research.